Cargando…
Therapeutic benefits of distal ventricular pacing in mid-cavity obstructive hypertrophic cardiomyopathy
INTRODUCTION: Hypertrophic cardiomyopathy (HCM) patients with left ventricular (LV) mid-cavity obstruction (LVMCO) often experience severe drug-refractory symptoms thought to be related to intraventricular obstruction. We tested whether ventricular pacing, guided by invasive haemodynamic assessment,...
Autores principales: | Malcolmson, James W., Hughes, Rebecca K., Joshi, Abhishek, Cooper, Jackie, Breitenstein, Alexander, Ginks, Matthew, Petersen, Steffen E., Mohiddin, Saidi A., Dhinoja, Mehul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350522/ https://www.ncbi.nlm.nih.gov/pubmed/35916371 http://dx.doi.org/10.1177/17539447221108816 |
Ejemplares similares
-
Apical Hypertrophic Cardiomyopathy: The Variant Less Known
por: Hughes, Rebecca K., et al.
Publicado: (2020) -
Novel Use of the Midas Rex Neurosurgical Drill to Release Silicone Glue Entrapped Pacing Leads
por: Breitenstein, Alexander, et al.
Publicado: (2016) -
Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy
por: Ricci, Fabrizio, et al.
Publicado: (2019) -
Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy
por: Hughes, Rebecca K., et al.
Publicado: (2023) -
Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)